Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07463378) titled 'Study of LUT017 Gel to Improve Healing of Skin Wounds After Removal of Benign Lesions in Healthy Adults' on March 5.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Antoni Ribas
Condition:
Wound Healing
Acute Skin Wounds
Intervention:
Drug: LUT017,Topical BRAF inhibitor
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: April 2026
Target Sample Size: 9
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/stu...